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Background:  Septic  arthritis  is  a  diagnostic  and  therapeutic  emergency  that  threatens  both  life and  func-
tion. The  primary  objective  of  this  study  was  to  assess  the  efﬁcacy  on  the infectious  process  of arthroscopic
treatment  in patients  with  septic  arthritis  of native  joints.  The  secondary  objective  was  to  identify  fac-
tors  predicting  failure to achieve  infection  resolution  after  arthroscopic  treatment.  We  hypothesised  that
arthroscopy  was  the  appropriate  treatment  strategy.
Material  and  methods:  Forty-six  cases  of  septic  arthritis  in  46  patients  with  a mean  age  of  46 years
(range,  18–72  years)  were  retrospectively  reviewed.  The  cause  of  the  septic  arthritis  was  haematogenous
dissemination  in  39.1%  of patients,  surgery  in  34.8%,  a local  injection  in  19.6%,  and  trauma  in  6.5%. The
involved  joint  was  the knee  in  32  patients,  the  shoulder  in  6, the  hip  in  3, the  ankle  in  3, and  the  elbow  in 2.
All  patients  underwent  arthroscopic  joint  lavage,  with  or  without  synovectomy  depending  on  the  Gächter
stage.  Dual  antibiotic  therapy  was  given  routinely  after  the  procedure.  For  each  patient,  we  assessed  time
to treatment,  intraoperative  ﬁndings  according  to  the Gächter  classiﬁcation,  cultures  of drainage-ﬂuids,
and  whether  repeat  arthroscopic  lavage  was  required.  Recovery  of  the infection  was  deﬁned  as  absence
of clinical  or laboratory  signs  of infection  at last  follow-up.
Results: Mean  follow-up  was  42  months  (range,  1–120).  Mean  time  from  symptom  onset  to arthroscopic
treatment  was  7.5  days. Full  recovery  of  the  infection  was  achieved  in  93%  of patients,  although  25%
required  more  than  one  arthroscopic  lavage.  Factors  signiﬁcantly  associated  with  arthroscopic  treatment
failure were  Gächter  stage  III  or IV  and  positive  drainage-ﬂuid  cultures  after 24  h.
Conclusion:  Arthroscopic  treatment  is indicated  in all patients  with  septic  arthritis  on  native  joints.  The
procedure  should  be  repeated  if  the initial  course  is unfavourable.
Level  of evidence:  IV. Retrospective  study.
©  2015  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
Septic arthritis of a native joint is a serious condition. Prompt
iagnosis and management are essential to avoid functional
mpairments and life-threatening complications. The incidence of
eptic arthritis is estimated at 1 to 10 cases per 100,000 population
er year and increases after 50 years of age [1].
The knee is the most common site of septic arthritis, followed
y the shoulder, hip, and ankle [2]. Mortality is about 10% overall,
ith rates of up to 30% in patients older than 60 years and in those
ith involvement of several joints or comorbidities [3–7]. Residual
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877-0568/© 2015 Elsevier Masson SAS. All rights reserved.functional impairments have been reported in about half the cases
[8–10].
The many treatments advocated to date include repeated
non-operative needle aspiration, open surgical synovectomy, and
arthroscopic management by joint lavage with or without synovec-
tomy. The indications of arthroscopic treatment in septic arthritis of
native joints remain ill-deﬁned, most notably regarding the criteria
for performing repeat arthroscopic lavage [11–13]. We  neverthe-
less hypothesised that arthroscopy was the most effective approach
in septic arthritis of native joints.
Our primary objective in designing this study was to evaluate
the clinical and bacteriological outcomes of arthroscopic treatment
in patients with septic arthritis of native joints. Our secondary
objective was  to identify intraoperative and/or postoperative fac-
tors that predicted failure of arthroscopic treatment in providing
resolution of the infectious process.
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Table 3
Causative bacteria identiﬁed and recovery rates for each.
Bacteria n (%) Recovery rate (%)
Staphylococcus aureus 22 (47.8) 91
Coagulase-negative Staphylococcus 7 (15.2) 85.1
Staphylococcus epidermidis 5 (10.8) 100
Propionibacterium acnes 3 (6.5) 100
Gonococcus 2 (4.3) 100
Streptococcus A 1 (2.2) 100
Streptococcus G 1 (2.2) 100
Staphylococcus capitis 1 (2.2) 100
Pneumococcus 1 (2.2) 100
Corynebacterium 1 (2.2) 100
Enterobacter cloacae 1 (2.2) 1002 F. Aïm et al. / Orthopaedics & Traumato
. Material and methods
Forty-six cases of septic arthritis of native joints managed
rthroscopically, in 46 patients, 29 males and 17 females with a
ean age at initial management of 46 years (range, 18–72 years)
ere retrospectively reviewed. Of these 46 patients, 8 (17.4%) had
isk factors for immunodeﬁciency (insulin-dependent or requiring
iabetes, n = 3; glucocorticoid therapy, n = 2; lymphoedema, n = 1;
irrhosis of the liver, n = 1; and decline in general health, n = 1).
The cause of the infection was haematogenous dissemination
n 39.1% of cases, arthroscopy in 23.9%, surgery in 10.9%, a local
njection in 19.6%, and trauma in 6.5% (Table 1). The joint involved
as the knee in 32 patients, shoulder in 6, hip in 3, ankle in 3, and
lbow in 2.
The diagnosis of septic arthritis relied on a set of converg-
ng arguments including suggestive local clinical features (joint
ain and effusion, local warmth, and functional impairment) with
r without systemic signs of infection (fever and/or chills) and
aboratory evidence of systemic inﬂammation (leucocytosis and
-reactive protein [CRP] elevation). Joint aspiration and blood
ultures were performed routinely in all patients before the arthro-
copic procedure. The identiﬁcation of micro-organisms in the joint
spirate conﬁrmed the suspected diagnosis of septic arthritis.
Mean time from the onset of local infectious symptoms to
rthroscopy was 7.5 days (range, 1–25 days) overall, 4 days in
he group with haematogenous septic arthritis, and 13 days in the
roup with post-arthroscopy septic arthritis (Table 2).
.1. Operative technique
The ﬁrst step of the arthroscopic procedure was  aspiration of
he joint ﬂuid, of which samples were sent to the microbiologi-
al laboratory. Next, the stage of the septic arthritis was assessed
sing the Gächter classiﬁcation system [14]. A second portal was
hen created for introduction of the instruments and irrigation. At
he knee, a third supero-lateral portal was created routinely for
rrigation and drainage.
High-volume arthroscopic lavage of the joint was  performed
ith saline to remove all ﬁbrin deposits and false membranes
using a powered shaver). The joint was irrigated until the ﬂuid
as clear. No antibiotics or antiseptics were added to the irrigation
olution. Synovial-membrane biopsies were collected routinely
or microbiological studies. In all, ﬁve joint ﬂuid and synovial-
embrane samples were sent to the laboratory for each joint.
taphylococcus aureus was identiﬁed in nearly half the cases (22/46)
Table 3).
able 1
ause of the infection.
n (%)
Haematogenous 18 (39.1)
After arthroscopy 11 (23.9)
After surgery 5 (10.9)
After a local injection 9 (19.6)
Post-traumatic 3 (6.5)
able 2
ime to arthroscopic treatment.
Days with symptoms before the ﬁrst
arthroscopic procedure
Gächter I 2 ± 1.2
Gächter II 7.3 ± 6.3
Gächter III 13 ± 5.4
Gächter IV 15 ± 4.3Chlamydia 1 (2.2) 100
Synovectomy was  performed in 33 of the 46 patients. The
criterion for synovectomy was gross involvement of the synovial-
membrane (Gächter stage II, III, or IV). Synovectomy was as
complete as possible to maximise the reduction of the bacterial
burden.
The portals were closed using non-absorbable nylon suture. A
drain was  routinely placed in the joint at the end of the procedure,
and the drainage-ﬂuid was cultured on the ﬁrst, third, and ﬁfth
days after the procedure. Two  systemic antibiotics were started
immediately after intraoperative sample collection then adjusted
based on the microbiological ﬁndings and a multidisciplinary dis-
cussion among infectious-disease specialists, microbiologists, and
orthopaedic surgeons.
2.2. Follow-up and assessments
Joint mobilisation was started immediately to avoid stiffness.
For lower-limb joints, weight bearing was deferred for several days
or weeks depending on the time-course of the local signs of inﬂam-
mation and on the intraoperative appearance of the cartilage.
Dual antibiotic therapy was continued for 45 days, either
parenterally or orally depending on the antibiotics used. An
infectious-diseases specialist monitored the safety of the antibiotic
treatment.
We deﬁned full recovery from the infectious process as the con-
comitant presence of the following criteria: apyrexia, decrease in
joint effusion size, decrease in CRP levels with special attention
to the changes in results of serial assays (and without requiring a
return to normal), and negative drainage-ﬂuid cultures.
Patients with an unfavourable course after 48–72 hours under-
went a second arthroscopic procedure involving joint lavage,
synovectomy if not performed initially, and drainage of the joint.
At last follow-up, the following outcome measures were
recorded: positive drainage-ﬂuid cultures after arthroscopic treat-
ment, need for repeat arthroscopy, and number of deaths during
the immediate post-arthroscopy period.
2.3. Statistical analysis
The statistical analysis was done using Prism software (Graph-
Pad, La Jolla, CA, USA). Values of P ≤ 0.05 were considered
signiﬁcant. We  used Chi2 tests to look for signiﬁcant differences
among qualitative variables and to compare outcomes across
Gächter stages. Pearson’s linear correlation coefﬁcients were com-
puted to assess potential correlations linking infection severity to
the need for repeat arthroscopy and absence of infection resolution
to time to management.
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Table  4
Outcomes of arthroscopic treatment by Gächter stage.
Gächter stage n (%) positive
Redon drains
on D1
n (%) of repeat
arthroscopies
n (%) deﬁnitive
recoveries
Stage I (n = 13) 1 (7.7) 0 (0) 13 (100)
Stage II (n = 21) 9 (42.8) 5 (23.8) 21 (100)
Stage III (n = 9) 6 (66.7) 5 (55.6)a 7 (77.8)
Stage IV (n = 3) 1 (33.3) 3 (100)a 2 (66.7)
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tomy, in terms of both infection eradication and joint function.a Repeat lavage rates differed signiﬁcantly between Gächter stages I and III
P  = 0.0048) and between Gächter stages I and IV (P = 0.0018)
. Results
All 46 patients were re-evaluated after a mean of 42 months
range, 1–120 months).
Resolution of the infection was achieved at last follow-up in
3% of patients. However, one-fourth of these patients required a
econd arthroscopic procedure, which was performed a mean of 5
ays after the initial procedure (range, 3–8 days).
All 13 patients with Gächter stage 1 disease achieved a full
ecovery after a single arthroscopic procedure. All 21 Gächter
tage 2 patients also achieved a full recovery, but among them,
 (23.8%) required a second arthroscopic procedure, after a mean
ime from the ﬁrst procedure of 5.2 days (range, 3–8 days). Of the
 patients with Gächter stage 3 arthritis, 5 (55.5%) required a sec-
nd arthroscopy procedure and 7 (78%) achieved a full recovery.
inally, all 3 patients with Gächter stage 4 disease required a second
rthroscopic procedure and 2 achieved a full recovery (Table 4).
Failure to achieve resolution of the infection was managed by
evision surgery, in one stage or two stages (with an antibiotic-
mpregnated spacer), after a mean of 17 days (range, 30–300 days).
The following factors did not predict failure of the arthroscopic
reatment to resolve the infection: age, sex, comorbidities, time
o management, cause of the septic arthritis, and causative micro-
rganism (Table 3). In contrast, factors signiﬁcantly predictive of
ailure were Gächter stage 3 or 4 and positive cultures of drainage-
uid sampled 24 hours after arthroscopy (P < 0.05) (Table 4). Thus,
he proportion of patients who recovered with a single arthro-
copic procedure was 93% when the 24-hour drainage sample was
egative and 35% when it was positive (P < 0.001). Thus, positive
ultures of the 24-hour drainage-ﬂuid sample had a very high pos-
tive predictive value (PPV) for arthroscopic treatment failure (0.82;
I, 0.65–0.93).
. Discussion
In our experience, arthroscopic management of septic arthri-
is on native joints ensured resolution of the infection in 93% of
atients. This result is consistent with the main previous stud-
es and conﬁrms the superiority of arthroscopic treatment over
epeated needle aspiration or arthrotomy, for which the reported
ecovery rates are only 79% and 84% [8]. Arthroscopic treatment
radicated the infection in over 93% of our patients, although in
ne fourth of cases a second arthroscopic procedure was  required.
epeat arthroscopic treatment should be widely used and con-
titutes an integral part of the management of septic arthritis.
ll patients with septic arthritis and no marked improvement
mmediately after the ﬁrst arthroscopic procedure should have the
rocedure repeated. This aggressive treatment strategy consider-
bly increases the recovery rate (from 70% in our population after
 single arthroscopic procedure to over 90% after two arthroscopic
rocedures) and is associated with only minimal adverse effects
10,12,14–17]. Arthroscopic treatment of septic arthritis provides
ood functional outcomes in 80% of cases [10,13].Surgery & Research 101 (2015) 61–64 63
The severity stage as assessed according to Gächter was the
strongest prognostic factor in our study. All patients with Gächter
stage 1 or 2 disease experienced full resolution of the infectious
process, compared to 78% and 67% of patients with stage 3 and
4 disease, respectively. Symptom duration or time to manage-
ment, which directly inﬂuence the Gächter stage, is also among
the main predictors of treatment outcomes in septic arthritis
[9,13,18]. However, this factor was not statistically signiﬁcant in
our study. S. aureus (particularly when resistant to methicillin) as
the causative organism has been associated with poor outcomes
of septic arthritis, so that presence of this organism, in itself, may
indicate repeat arthroscopic treatment in nearly every case [6,10].
In our study, none of the microbiological factors, including the
presence of S. aureus,  signiﬁcantly predicted failure of arthroscopic
treatment for septic arthritis.
Positive cultures of the ﬁrst drainage-ﬂuid sample, collected
after 24 h, was a strong predictor of treatment failure (PPV, 0.82).
Thus, 93% of patients with a negative 24-h sample achieved erad-
ication of the infection after a single arthroscopic procedure,
compared to 35% of those with a positive 24-h sample, in our study
focussed speciﬁcally on septic arthritis of native joints. The result
of the ﬁrst drainage-ﬂuid culture (24 hours after the procedure)
reﬂects the quality of the joint lavage and amount of residual intra-
articular bacteria. The results of routine drainage-ﬂuid cultures
after arthroscopic treatment of septic arthritis have prompted us
to modify our postoperative management strategy: patients with a
positive 24-h drainage-ﬂuid culture now routinely undergo a sec-
ond arthroscopic procedure, without waiting for the results of the
day-3 and day-5 samples. In addition, we administer the antibiotics
intravenously until the drainage-ﬂuid cultures become negative.
Thus, the switch to oral antibiotic therapy occurs only after the
drainage-ﬂuid is negative, to avoid the risk of emerging bacterial
resistance, particularly in patients with S. aureus infection.
Post-arthroscopy septic arthritis runs a more indolent course
and is often due to slowly growing bacteria (e.g., coagulase-
negative staphylococci or anaerobes), two  facts that explain the
longer time to treatment [19,20]. Nevertheless, the management
strategy is the same, with ﬁrst-line arthroscopy for an evaluation
of the joint, lavage, and synovectomy. There is no reason to remove
a transplant used for ligament reconstruction or ﬁxation material,
and the most important procedure is synovectomy, which must
be as complete as possible [21,22]. The immediate course is rarely
favourable, and repeat arthroscopic treatment is often needed (half
the cases in our study), although the ﬁnal infection eradication rate
is greater than 85%.
The main limitations of our study are the single-centre design,
small number of patients, and retrospective design, which pre-
cluded the identiﬁcation of other factors predicting treatment
failure, as well as the analysis of speciﬁc subgroups. Finally,
we did not collect data allowing an evaluation of functional
outcomes.
5. Conclusion
Arthroscopy is the most appropriate procedure for treating
septic arthritis on native joints. By allowing an extensive evalu-
ation of the joint, arthroscopy provides prognostic information by
indicating the Gächter stage. Arthroscopy allows joint lavage, syn-
ovectomy, and joint drainage. Treatment-related complications are
minimal. In the treatment of septic arthritis, arthroscopy provides
better outcomes compared to repeated needle aspiration or arthro-The need for repeat arthroscopy should be recognised promptly
in patients without immediate marked improvements and, in par-
ticular, in those whose drainage-ﬂuid cultures are positive. This
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trategy saves time and increases the chances of eradicating the
nfection.
Even in patients with septic osteoarthritis (Gächter stage
), arthroscopic treatment can eradicate the infection in some
nstances, thereby avoiding or postponing the need for joint
esection and replacement [23].
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